People: Immucor, Inc. (BLUD.O)

BLUD.O on Nasdaq

18.71USD
9 Feb 2010
Price Change (% chg)

$0.04 (+0.21%)
Prev Close
$18.67
Open
$18.82
Day's High
$19.00
Day's Low
$18.59
Volume
667,414
Avg. Vol
557,960
52-wk High
$29.05
52-wk Low
$11.24

view people for:

Summary

Name Age Since Current Position
Rosen, Joseph 65 2006 Chairman of the Board
De Chirico, Gioacchino 56 2006 President, Chief Executive Officer, Director
Flynt, Richard 50 Chief Financial Officer, Vice President
Crouse, Geoffrey 38 2009 Chief Operating Officer, Vice President
Eatz, Ralph 65 2003 Senior Vice President, Chief Scientific Officer, Director
Moise, Philip 59 2007 Vice President, General Counsel, Secretary
Lancaster, Ronny 58 2008 Director
Holland, Paul 72 2008 Director
Clouser, James 58 2008 Director
Perkins, Chris 47 2008 Director
Mintz, Paul 2010 Director
» Insider Trading

Biographies

Name Description
Rosen, Joseph Joseph E. Rosen has been a Director of Immucor, Inc. since its founding in 1982, except for a three-year hiatus from 1995 to 1998, and has served as Chairman of the Board of Directors since September 2006. He has served as Director – Business Development and Planning for BioLife Plasma Services since 2002. Previously, Mr. Rosen had been employed in various capacities, including CFO, at Sera-Tec Biologicals since its inception in 1969, ultimately serving as its CEO from 1986 until 2001. Mr. Rosen is currently serving on the Board of the PPTA Source, the plasma collection industry trade group, and has been a member of the board of directors of several public and private health care companies. He has over 40 years of experience in the blood banking industry.
De Chirico, Gioacchino Dr. Gioacchino De Chirico, a Director of Immucor, Inc. since 1994, was appointed as Chief Executive Officer of the Company in September 2006. He has served as President of the Company since July 2003. He also served as Chief Executive Officer from April 2004 through October 2004. Prior to assuming his position as President, Dr. De Chirico served as President of Immucor Italia S.p.A., a subsidiary of the Company, from February 1994 through May 1998, then as the Company’s Director of European Operations from May 1998 through July 2003. From 1989 until 1994, Dr. De Chirico was employed by Ortho Diagnostic Systems, Inc., a subsidiary of Johnson & Johnson, as General Manager, Immunocytometry, with worldwide responsibility.
Flynt, Richard Richard A. Flynt was appointed as Chief Financial Officer of Immucor, Inc. in December 2007. Mr. Flynt is a Certified Public Accountant with more than 25 years of financial management experience. He has most recently served as Vice President – Finance with McKesson Corporation in Alpharetta, Georgia. From July 2004 through January 2007, he was Senior Vice President – Corporate Controller & Chief Accounting Officer with Per-Se Technologies, Inc., which was acquired by McKesson Corporation in January 2007. From 1997 through 2004, he served in a variety of senior financial management positions with GNB Technologies, Inc., Exide Technologies, Inc. and GTS Energy. Prior to that, he had 15 years of public accounting experience with Ernst & Young LLP. Mr. Flynt earned a BBA and Masters of Accounting from University of Georgia.
Crouse, Geoffrey Mr. Geoffrey S. Crouse is Chief Operating Officer, Vice President of Immucor, Inc. Effective August 3, 2009, Mr. Crouse was appointed Chief Operating Officer. Prior to his appointment, since 2006 Mr. Crouse served as Vice President of the Life Sciences Business Unit at Millipore Corporation, a provider of technologies, tools and services for the global life sciences industry. Prior to that, Mr. Crouse worked at F. Hoffman-La Roche Ltd., a healthcare company focusing on diagnostic and pharmaceutical products, serving as the Head of Market Development and Government Affairs in the Diagnostics Division from 2004 to 2006 and as the Senior Marketing Manager in Molecular Diagnostics from 2003 to 2004. Mr. Crouse earned a B.A. from Boston College and an MBA and Masters of Public Health from University of California at Berkley.
Eatz, Ralph Ralph A. Eatz has been a Director of Immucor, Inc. since its founding in 1982. He has worked in the blood banking reagent field for over 30 years. Mr. Eatz served as Vice President – Operations of the Company from its founding until being appointed Senior Vice President – Operations in 1988. In July 2003, Mr. Eatz assumed his present position of Senior Vice President – Chief Scientific Officer.
Moise, Philip Philip H Moise was appointed as Vice President, General Counsel and Secretary of Immucor, Inc. in April 2007. Before joining the Company, Mr. Moïse was in the private practice of law, most recently as a partner and Co-Chair of Life Sciences at Sutherland Asbill & Brennan LLP in Atlanta. During a 30-year career in private practice, he represented over 35 public and private companies in the life sciences and medical products industries, and he had represented the Company for over 20 years. Mr. Moïse graduated with honors from The Citadel and Duke University School of Law.
Lancaster, Ronny Ronny B. Lancaster, a Director of Immucor, Inc. since 2008, has served as Senior Vice President of Federal Government Relations for Assurant, Inc. since 2005. He previously served as Senior Vice President and Chief Operating Officer of Morehouse School of Medicine in Atlanta, and Executive Assistant to the Secretary and Principal Deputy Assistant Secretary for Planning and Evaluation of the U.S. Department of Health and Human Services. Mr. Lancaster earned a B.A. in Economics from the Catholic University of America, an MBA from the Wharton School of the University of Pennsylvania, and a J.D. from Georgetown University Law Center. He currently sits on the Board of Directors of OraSure Technologies, Inc., an oral fluid diagnostic company, and on the Medical Advisory Board of Henry Schein, Inc., a distributor of healthcare products and services.
Holland, Paul Paul V. Holland, M.D., a Director of Immucor, Inc. since 2008, has served as the Scientific Director of Delta Blood Bank in Stockton, California since 2004 and as the Medical Director of Pacificord, a division of Healthbanks Biotech USA Inc., since 2008. He has been involved in blood banking and transfusion medicine for over 40 years including service as Chief of the Blood Bank Department of the Clinical Center of the National Institutes of Health from 1974 to 1983, Medical Director and CEO of the Sacramento Medical Foundation Blood Center, currently doing business as BloodSource, from 1984 to 2004, and as a Clinical Professor of Medicine and Pathology in the Division of Hematology/Oncology at UC Davis Medical Center from 1984 to the present. Dr. Holland has also advised biotech companies, U.S and foreign governments, agencies and non-governmental organizations, including the World Health Organization; and he has served as President of the International Society of Blood Transfusion, and as a member of the nominating committee for the Nobel Prize in Medicine and Physiology.
Clouser, James James F. Clouser, a Director of Immucor, Inc. since 2008, served from 1988 to 1999 as President, CEO and a board member of SteriGenics International, a global leader in medical device sterilization services, where he led the initial public offering of SteriGenics shares. He has also served as President, COO or CFO of several public and private healthcare and technology companies, including Ion Beam Applications, S.A., Attain Inc. and Diasonics Inc. Mr. Clouser holds an MBA in Finance from Wayne State University, Detroit, MI and a Masters of Accounting from Rochester Institute of Technology, Rochester, NY. He is a member of the American Institute of Certified Public Accountants.
Perkins, Chris Chris E. Perkins, a Director of Immucor, Inc. since 2008, practiced seven years as a CPA in public accounting then served 15 years in senior management positions in finance, accounting, corporate development and operations of several publicly traded companies. He currently serves as the Executive Vice President and Chief Financial Officer of Eclipsys Corporation, a provider to healthcare organizations of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services. Prior to that, from 2001 to 2007, he served as the CFO then COO of Per-Se Technologies, a systems technology and outsource service provider to the healthcare industry that was acquired by McKesson Corporation. He also served as the Executive Vice President and Chief Operating Officer of Emageon Inc., a healthcare technology company, from December 2007 until he resigned in July 2008.
Mintz, Paul Paul D. Mintz, M.D. has been appointed as Director of Immucor, Inc. effective January 1, 2010. Dr. Mintz has been involved in blood banking and transfusion medicine for more than 30 years. He is a tenured Professor of Pathology and Medicine at the University of Virginia School of Medicine. He also serves as director of the University of Virginia Health System's Clinical Laboratories and Transfusion Medicine Services as well as Chief of the Department of Pathology's Division of Clinical Pathology. Dr. Mintz is also a co-medical director of Virginia Blood Services. Dr. Mintz has served on numerous national and regional boards and committees throughout his career for such agencies and organizations as the Centers for Medicare and Medicaid Services, the National Blood Foundation and the AABB (formerly the American Association of Blood Banks). He is a past president of AABB and served for several years on its FDA Advisory Committee, including as past chair. Dr. Mintz was a recipient of a Transfusion Medicine Academic Award from the National Heart, Lung and Blood Institute. He has authored or co-authored more than 100 journal articles in blood banking and transfusion medicine.

Basic Compensation

Name Fiscal Year Total
Rosen, Joseph --
De Chirico, Gioacchino 1,490,880
Flynt, Richard 548,296
Crouse, Geoffrey --
Eatz, Ralph 952,303
Moise, Philip 958,155
Lancaster, Ronny --
Holland, Paul --
Clouser, James --
Perkins, Chris --
Mintz, Paul --
As Of 30 May 2009

Options Compensation

Name Options Value
Rosen, Joseph 0 0
De Chirico, Gioacchino 674,998 11,548,587
Flynt, Richard 0 0
Crouse, Geoffrey 0 0
Eatz, Ralph 1,073,610 19,258,128
Moise, Philip 0 0
Lancaster, Ronny 0 0
Holland, Paul 0 0
Clouser, James 0 0
Perkins, Chris 0 0
Mintz, Paul 0 0

Insider Trading

Name Shares Traded Price
FLYNT RICHARD A JR 12,326 $0.00
ROSEN JOSEPH E 2,422 $0.00
CLOUSER JAMES F 2,422 $0.00
DECHIRICO GIOACCHINO 34,821 $0.00
PERKINS CHRIS E 2,422 $0.00
MOISE PHILIP H 19,831 $0.00
HOKETSU HIROSHI 2,422 $0.00
HOLLAND PAUL V 2,422 $0.00
EATZ RALPH A 17,399 $0.00
LANCASTER RONNY B 2,422 $0.00
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $25.95
EATZ RALPH A 10,000 $25.00
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $25.08
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $25.12
EATZ RALPH A 10,000 $26.98
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $27.67
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $0.89
EATZ RALPH A 10,000 $27.97
EATZ RALPH A 10,000 $28.01
» Full list on Insider Trading
view people for: